Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 377


Expression of microRNA-30a-5p in drug-resistant and drug-sensitive ovarian cancer cell lines.

Liu J, Wu X, Liu H, Liang Y, Gao X, Cai Z, Wang W, Zhang H.

Oncol Lett. 2016 Sep;12(3):2065-2070. Epub 2016 Jul 8.


miR-200c Regulation of Metastases in Ovarian Cancer: Potential Role in Epithelial and Mesenchymal Transition.

Sulaiman SA, Ab Mutalib NS, Jamal R.

Front Pharmacol. 2016 Aug 23;7:271. doi: 10.3389/fphar.2016.00271. eCollection 2016. Review.


MiR-200c promotes bladder cancer cell migration and invasion by directly targeting RECK.

Cheng Y, Zhang X, Li P, Yang C, Tang J, Deng X, Yang X, Tao J, Lu Q, Li P.

Onco Targets Ther. 2016 Aug 16;9:5091-9. doi: 10.2147/OTT.S101067. eCollection 2016.


TGF-β1 regulating miR-205/miR-195 expression affects the TGF-β signal pathway by respectively targeting SMAD2/SMAD7.

Duan Y, Chen Q.

Oncol Rep. 2016 Oct;36(4):1837-44. doi: 10.3892/or.2016.5023. Epub 2016 Aug 17.


miR-203 is involved in the laryngeal carcinoma pathogenesis via targeting VEGFA and Cox-2.

Xu L, Shen B, Chen T, Dong P.

Onco Targets Ther. 2016 Jul 26;9:4629-37. doi: 10.2147/OTT.S96053. eCollection 2016.


miR-145 suppresses breast cancer cell migration by targeting FSCN-1 and inhibiting epithelial-mesenchymal transition.

Zhao H, Kang X, Xia X, Wo L, Gu X, Hu Y, Xie X, Chang H, Lou L, Shen X.

Am J Transl Res. 2016 Jul 15;8(7):3106-14. eCollection 2016.


The highly expressed 5'isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration.

Salem O, Erdem N, Jung J, Münstermann E, Wörner A, Wilhelm H, Wiemann S, Körner C.

BMC Genomics. 2016 Aug 8;17:566. doi: 10.1186/s12864-016-2869-x.


MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12.

Liang T, Li L, Cheng Y, Ren C, Zhang G.

Onco Targets Ther. 2016 Jul 15;9:4307-15. doi: 10.2147/OTT.S90976. eCollection 2016.


Genetic and molecular changes in ovarian cancer.

Hollis RL, Gourley C.

Cancer Biol Med. 2016 Jun;13(2):236-47. doi: 10.20892/j.issn.2095-3941.2016.0024.


MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2.

Deng B, Wang B, Fang J, Zhu X, Cao Z, Lin Q, Zhou L, Sun X.

Sci Rep. 2016 Jul 4;6:28301. doi: 10.1038/srep28301.


The role and expression of miR-100 and miR-203 profile as prognostic markers in epithelial ovarian cancer.

Azizmohammadi S, Azizmohammadi S, Safari A, Kosari N, Kaghazian M, Yahaghi E, Seifoleslami M.

Am J Transl Res. 2016 May 15;8(5):2403-10. eCollection 2016.


High-throughput sequencing reveals differential expression of miRNAs in prehierarchal follicles of laying and brooding geese.

Yu J, He K, Ren T, Lou Y, Zhao A.

Physiol Genomics. 2016 Jul 1;48(7):455-63. doi: 10.1152/physiolgenomics.00011.2016. Epub 2016 May 6.


MicroRNA-183 correlates cancer prognosis, regulates cancer proliferation and bufalin sensitivity in epithelial ovarian caner.

Chen H, Zhang L, Zhang L, Du J, Wang H, Wang B.

Am J Transl Res. 2016 Apr 15;8(4):1748-55. eCollection 2016.


Histone deacetylase inhibition regulates miR-449a levels in skeletal muscle cells.

Poddar S, Kesharwani D, Datta M.

Epigenetics. 2016 Aug 2;11(8):579-87. doi: 10.1080/15592294.2016.1188247. Epub 2016 May 16.


Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).

Gambari R, Brognara E, Spandidos DA, Fabbri E.

Int J Oncol. 2016 Jul;49(1):5-32. doi: 10.3892/ijo.2016.3503. Epub 2016 May 4.


miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression.

Sun TY, Xie HJ, He H, Li Z, Kong LF.

Am J Transl Res. 2016 Feb 15;8(2):1037-46. eCollection 2016.


MicroRNAs of Toxocara canis and their predicted functional roles.

Ma G, Luo Y, Zhu H, Luo Y, Korhonen PK, Young ND, Gasser RB, Zhou R.

Parasit Vectors. 2016 Apr 23;9:229. doi: 10.1186/s13071-016-1508-3.


Comparison of Methodologies to Detect Low Levels of Hemolysis in Serum for Accurate Assessment of Serum microRNAs.

Shah JS, Soon PS, Marsh DJ.

PLoS One. 2016 Apr 7;11(4):e0153200. doi: 10.1371/journal.pone.0153200. eCollection 2016.


Experimental procedures to identify and validate specific mRNA targets of miRNAs.

Elton TS, Yalowich JC.

EXCLI J. 2015 Jul 2;14:758-90. doi: 10.17179/excli2015-319. eCollection 2015. Review.


Differential miRNA-Expression as an Adjunctive Diagnostic Tool in Neuroendocrine Tumors of the Lung.

Demes M, Aszyk C, Bartsch H, Schirren J, Fisseler-Eckhoff A.

Cancers (Basel). 2016 Mar 25;8(4). pii: E38. doi: 10.3390/cancers8040038.

Items per page

Supplemental Content

Write to the Help Desk